Hemant Kulkarni
Hemant Kulkarni
Renal Physician
Verified email at health.wa.gov.au
Title
Cited by
Cited by
Year
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes
DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MWY Foo, ...
Journal of the American Society of Nephrology 23 (6), 1097-1107, 2012
1902012
Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease
P Ferrari, H Kulkarni, S Dheda, S Betti, C Harrison, TGS Pierre, JK Olynyk
Clinical Journal of the American Society of Nephrology 6 (1), 77-83, 2011
1212011
Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure
S Prakash, DP Pande, S Sharma, D Sharma, CS Bal, H Kulkarni
Journal of renal nutrition 14 (2), 89-96, 2004
942004
The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial
DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MWY Foo, ...
Nephrology Dialysis Transplantation 27 (12), 4445-4453, 2012
902012
The Effects of Biocompatible Compared with Standard Peritoneal Dialysis Solutions on Peritonitis Microbiology, Treatment, and Outcomes: The Balanz Trial
bal ANZ Trial Writing Committee:
Peritoneal Dialysis International 32 (5), 497-506, 2012
652012
High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population
R Singer, HC RHODES, G Chin, H Kulkarni, P Ferrari
Nephrology 13 (1), 17-22, 2008
552008
Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin
R Howman, H Kulkarni
Nephrology Dialysis Transplantation 22 (5), 1462-1464, 2007
402007
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
SD Roger, CA Gaillard, AH Bock, F Carrera, KU Eckardt, DB Van Wyck, ...
Nephrology Dialysis Transplantation 32 (9), 1530-1539, 2017
332017
Escherichia coli ‘O’group serological responses and clinical correlations in epidemic HUS patients
H Kulkarni, PN Goldwater, A Martin, KA Bettelheim
Comparative immunology, microbiology and infectious diseases 25 (4), 249-268, 2002
322002
Successful treatment of renal allograft and bladder malakoplakia with minimization of immunosuppression and prolonged antibiotic therapy
AL Graves, M Texler, L Manning, H Kulkarni
Nephrology 19, 18-21, 2014
162014
Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis
R Holman, JK Olynyk, H Kulkarni, P Ferrari
Nephrology 22 (2), 114-117, 2017
152017
balANZ Trial Investigators: The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: The balANZ …
DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MW Foo, ...
Nephrol Dial Transplant 27 (12), 4445-4453, 2012
152012
What are the consequences of volume expansion in chronic dialysis patients? Defining and measuring fluid overload in hemodialysis patients
M Hecking, H Rayner, P Wabel
Seminars in dialysis 28 (3), 242-247, 2015
132015
Intra‐ureteric capsaicin in loin pain haematuria syndrome: efficacy and complications
D Playford, H Kulkarni, M Thomas, J Vivian, A Low, J Mander, D Perlman, ...
BJU international 90 (6), 518-521, 2002
132002
Performance evaluation of full scale wastewater treatment facility for finished leather industry
SN Kaul, PK Mukherjee, TA Sihorwala, H Kulkarni, T Nandy
Journal of Environmental Science & Health Part A 28 (6), 1277-1286, 1993
111993
Subjective and quantitative assessment of patient fitness for cadaveric kidney transplantation: the “equity penalty”
MAB Thomas, G Luxton, HR Moody, AJ Woodroffe, H Kulkarni, W Lim, ...
Transplantation 75 (7), 1026-1029, 2003
102003
Natriuretic peptides in the management of solid organ transplantation associated acute kidney injury: a systematic review and meta-analysis
SU Nigwekar, H Kulkarni, CV Thakar
International journal of nephrology 2013, 2013
72013
balANZ Trial Investigators: The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: The balANZ trial
DW Johnson, FG Brown, M Clarke, N Boudville, TJ Elias, MW Foo, ...
Perit Dial Int 32, 497-506, 2012
72012
Causality of rhabdomyolysis and combined tetanus, diphtheria and acellular pertussis (Tdap) vaccine administration
H Kulkarni, N Lenzo, A McLean‐Tooke
The Journal of Clinical Pharmacology 53 (10), 1099-1102, 2013
32013
Randomized double blind placebo controlled trial of ketoanalogues in retardation of chronic renal failure in tropics
S Prakash, D Pande, K Suresh, H Kulkarni
Nephrology Dialysis Transplantation 18, 2003
32003
The system can't perform the operation now. Try again later.
Articles 1–20